SEC Form 4 · accession 0001209191-15-071207
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Krivulka
Director
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $12.80 | Sep 15, 2015 | A | 12,500 | A | — | Sep 14, 2023 | Common Stock | 12,500 | 12,500 | D |
| Restricted Stock UnitF2,F3 | — | Sep 15, 2015 | A | 15,000 | A | — | Sep 14, 2023 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This option was granted on September 15, 2015 and vests in equal monthly installments over the one-year period following the grant date.
- F2Each restricted stock unit represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
- F3This restricted stock unit award vests in full one year following the grant date.